| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000249602.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.048843466 |
Resistant |
| ENSG00000249602.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.028389245 |
Sensitive |
| ENSG00000249602.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.039851095 |
Sensitive |
